Table 3 Changes in BMF grade from baseline for individual patients, according to disease subtype and treatment cycle

PMF

3

2

n/a

n/a

n/a

n/a

Improved

PMF

3

2

1

1

n/a

1

Improved

PMF

3

3

n/a

3

n/a

n/a

Persistent grade 3

PMF

3

3

n/a

n/a

n/a

n/a

Persistent grade 3

PMF

3

2

3

n/a

2

2

Improved

PMF

3

2

2

2

2

n/a

Improved

PMF

2

3

3

n/a

n/a

n/a

Worsened

PMF

2

2

2

2

n/a

n/a

Stabilised

PMF

2

n/a

3

n/a

n/a

n/a

Worsened

PMF

2

n/a

3

n/a

n/a

n/a

Worsened

PMF

1

1

2

1

1

1

Stabilised

PMF

1

n/a

0

0

0

n/a

Improved

Post-PV MF

3

2

2

3

n/a

n/a

Persistent grade 3

Post-PV MF

3

3

n/a

3

3

3

Persistent grade 3

Post-PV MF

3

2

3

3

3

n/a

Persistent grade 3

Post-PV MF

2

3

2

2

n/a

2

Stabilised

Post-PV MF

2

1

0

0

n/a

0

Improved

Post-PV MF

2

3

3

3

2

3

Worsened

Post-PV MF

2

2

3

n/a

2

2

Stabilised

Post-PV MF

2

2

2

2

1

1

Improved

Post-ET MF

2

1

n/a

3

n/a

n/a

Worsened